File:RL33717 (IA RL33717-crs).pdf
From Wikimedia Commons, the free media repository
Jump to navigation
Jump to search
Size of this JPG preview of this PDF file: 424 × 600 pixels. Other resolutions: 170 × 240 pixels | 339 × 480 pixels | 543 × 768 pixels | 1,239 × 1,752 pixels.
Original file (1,239 × 1,752 pixels, file size: 396 KB, MIME type: application/pdf, 23 pages)
File information
Structured data
Captions
Summary
[edit]Licensing
[edit]Public domainPublic domainfalsefalse |
This United States Congress image is in the public domain. This may be because it was taken by an employee of the Congress as part of that person’s official duties, or because it has been released into the public domain and posted on the official websites of a member of Congress. As a work of the U.S. federal government, the image is in the public domain.
English ∙ Nederlands ∙ русский ∙ македонски ∙ español ∙ українська ∙ 日本語 ∙ 中文 ∙ 中文(简体) ∙ 中文(繁體) ∙ العربية ∙ +/− |
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 11:49, 20 June 2020 | 1,239 × 1,752, 23 pages (396 KB) | Fæ (talk | contribs) | Congressional Research Service RL33717-crs (User talk:Fæ/CCE volumes#Forks) (batch #6213) |
You cannot overwrite this file.
File usage on Commons
The following page uses this file:
Metadata
This file contains additional information such as Exif metadata which may have been added by the digital camera, scanner, or software program used to create or digitize it. If the file has been modified from its original state, some details such as the timestamp may not fully reflect those of the original file. The timestamp is only as accurate as the clock in the camera, and it may be completely wrong.
Short title | WIKILEAKS - Congressional Research Service - Pharmaceutical Patent Litigation Settlements: Implications for Competition and Innovation, November 4, 2008 |
---|---|
Image title | This report introduces and analyzes innovation policy issues concerning pharmaceutical patent litigation settlements. It begins with a review of pharmaceutical patent litigation procedures under the Hatch-Waxman Act. The report then introduces the concept of reverse payment settlements. Next, the report analyzes the status of reverse payment settlements under the antitrust laws. The report closes with a summary of congressional issues and alternatives. |
Author | Congressional Research Service : John R. Thomas, Resources, Science, and Industry Division |
Software used | WIKILEAKS - http://wikileaks.org/wiki/CRS-RL33717 - February 2, 2009 |
Conversion program | WIKILEAKS - http://wikileaks.org/wiki/CRS-RL33717 - February 2, 2009 |
Encrypted | no |
Page size |
|
Version of PDF format | 1.4 |